Literature DB >> 7738096

Nucleolar localisation of three Hox homeoproteins.

M T Corsetti1, G Levi, F Lancia, L Sanseverino, S Ferrini, E Boncinelli, G Corte.   

Abstract

Homeoproteins encoded by genes of the Hox family are nuclear proteins believed to act as transcription factors and to participate in the determination of the body plan. Here we show that in several vertebrate cells, they exhibit a subnuclear localisation associated with the nucleolus. We used monoclonal antibodies to study the distribution of three homeoproteins, namely HOXB7, HOXC6 and HOXD4. The immunoreactivity to antibodies against HOXC6 protein in Xenopus laevis embryonic tissues is restricted to one or two spots within the nucleus; this distribution partially overlaps that of fibrillarin, a protein of the fibrillar zone of the nucleoli. Indirect immunofluorescence analysis of the distribution of HOXB7 protein in 3T3 cells, and of HOXD4 protein in human neuroblastoma and Raji lymphoma cell lines and activated lymphocytes, results invariably in a nucleolar localisation. Purified nucleoli from stimulated T lymphocytes, and Raji cells contain an activity capable of binding, in a gel retardation assay, to an oligonucleotide specifically recognised by the HOXD4 homeoprotein. This activity is specifically removed by anti-HOXD4 antibodies and is found associated in southwestern blots with a single band with an apparent M(r) of 30,000, corresponding to that of recombinant HOXD4. The functional significance of the nucleolar localisation of Hox proteins remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738096     DOI: 10.1242/jcs.108.1.187

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

1.  Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.

Authors:  C P Chang; Y Jacobs; T Nakamura; N A Jenkins; N G Copeland; M L Cleary
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  A novel PF/PN motif inhibits nuclear localization and DNA binding activity of the ESX1 homeoprotein.

Authors:  Y T Yan; S M Stein; J Ding; M M Shen; C Abate-Shen
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Cloning and expression of a new HOXC6 transcript encoding a repressing protein.

Authors:  A Chariot; V Castronovo; P Le; C Gillet; M E Sobel; J Gielen
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

4.  Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ.

Authors:  J L Liu; L F Lee; Y Ye; Z Qian; H J Kung
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Temporal and spatial expression of Hoxa-2 during murine palatogenesis.

Authors:  A Nazarali; R Puthucode; V Leung; L Wolf; Z Hao; J Yeung
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

6.  The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.

Authors:  C P Chang; I de Vivo; M L Cleary
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

Review 7.  Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.

Authors:  J L Liu; H J Kung
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

8.  High-Throughput Discovery and Characterization of Human Transcriptional Effectors.

Authors:  Josh Tycko; Nicole DelRosso; Gaelen T Hess; Abhimanyu Banerjee; Aditya Mukund; Mike V Van; Braeden K Ego; David Yao; Kaitlyn Spees; Peter Suzuki; Georgi K Marinov; Anshul Kundaje; Michael C Bassik; Lacramioara Bintu
Journal:  Cell       Date:  2020-12-15       Impact factor: 66.850

9.  Rapid preparation of high-purity nuclear proteins from a small number of cultured cells for use in electrophoretic mobility shift assays.

Authors:  Yuqian Luo; Takeshi Hara; Yuko Ishido; Aya Yoshihara; Kenzaburo Oda; Masahiko Makino; Norihisa Ishii; Naoki Hiroi; Koichi Suzuki
Journal:  BMC Immunol       Date:  2014-12-20       Impact factor: 3.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.